Aminophylline versus furosemide for urine output after adult heart surgery
Official title: Comparison Between the Diuretic Effect of Aminophylline and Furosemide in Adult Patients Undergoing Cardiac Surgical Procedures: A Randomized Controlled Trial
Run by Cairo University · NCT07348510 · Data updated 2026-11-12
This trial will test whether aminophylline or furosemide helps increase urine output and lower the chance of kidney injury in adults having planned cardiac surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 106 (estimated) |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Cairo) |
| Status | Recruiting |
| Started | January 17, 2026 |
| Main results expected | July 26, 2026 |
| Study ends | July 26, 2026 |
| Registry record updated | January 21, 2026 |
| Trial ID | NCT07348510 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–65 undergoing elective cardiac surgical procedures on cardiopulmonary bypass with BMI between 20 and 40 kg/m2 who do not have end‑stage kidney disease or prior organ transplant.
✕Probably not a fit
Patients with stage‑5 chronic kidney disease, those already receiving dialysis, emergency surgery cases, or anyone with sensitivity to aminophylline or furosemide are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional comparison enrolls adults aged 18–65 undergoing elective cardiac surgery on cardiopulmonary bypass to compare the diuretic effects of aminophylline and furosemide. Eligible participants have BMI 20–40 and no end‑stage kidney disease, prior dialysis, or prior solid-organ transplant. The protocol administers one of the two diuretics perioperatively and monitors urine output, serum creatinine, and the incidence of cardiac surgery–associated acute kidney injury. The goal is to determine whether aminophylline reduces postoperative AKI frequency or better manages volume compared with a loop diuretic.
Why it matters
Potential benefit: If successful, the intervention could reduce postoperative acute kidney injury and improve fluid management after cardiac surgery.
How similar studies have gone: Prior analyses suggest loop diuretics have mixed effects on postoperative kidney function while some data indicate aminophylline may lower AKI frequency after cardiac surgery, so this comparison builds on limited and partly promising evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age from 18-65 years. * Both sexes. * All adult patients presenting for elective cardiac surgical procedures performed on cardiopulmonary bypass (Coronary artery bypass surgery, Cardiac valve repair and/or replacement, Repair of large septal defects, Repair and/or palliation of congenital heart defects, Transplantation, surgery of thoracic aneurysms.). * Body mass index (BMI) ranged between 20 and 40 kg/m2. Exclusion Criteria: * Sensitivity or contraindication to Aminophylline or furosemide * Stage-5 chronic kidney disease (CKD) \[Glomerular filtration rate (GFR) of less than 15 mL/min\]. * The presence of both factors (GFR less than 60 mL/min and albumin greater than 30 mg per gram of creatinine) along with abnormalities of kidney structure or function for greater than three months signifies chronic kidney disease. * Recipients of dialysis before surgery. * Recipients of solid-organ transplantation before surgery. * Emergency cardiac surgical procedures (e.g. left main coronary artery bypass graft, stuck valves, etc). * Patient refusal.
Where it's running
-
Cairo University
Cairo, Egypt Recruiting
Study contacts
- Study coordinator: Ahmed M Hassan, MSc
- Email: ahm33hassan@gmail.com
- Phone: 00201033752020
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Can Cardiac Cycle Efficiency predict high-dose vasoactive-inotropic needs after open-heart surgery?
This study tests whether Cardiac Cycle Efficiency measured after coming off bypass can predict which adults will need high doses of vasoactive and inotropic meds in the first 24 hours after open-heart surgery.
-
Electroacupuncture at ST36 to see if it lowers postoperative inflammation after heart surgery with bypass
This trial tests whether bilateral ST36 electroacupuncture given after cardiac surgery with bypass can reduce inflammation and improve recovery compared with a sham procedure.
-
Femoral versus radial arterial pressure monitoring during cardiac surgery
This trial tests whether femoral arterial catheters give more accurate continuous blood pressure readings than radial catheters in adults undergoing cardiac surgery with cardiopulmonary bypass.
-
Using fish oil to improve recovery in high-risk cardiac surgery patients
This study is testing if giving fish oil to high-risk heart surgery patients can help them recover better and reduce heart rhythm problems after surgery.
-
Bone substitutes with NIPSA for intrabony periodontal defects
This study tests two bone substitutes (GTO and GenOs) used with the NIPSA technique to see which supports better gum and bone healing in adults with Stage III periodontitis.
-
Renal perfusion during minimally invasive abdominal surgery using ultrasound and NIRS
Researchers will test if Doppler ultrasound RRI and NIRS-based rSO₂ can detect changes in kidney perfusion during elective laparoscopic surgery in adults with varying health status.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.